Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)

KOSDAQ:318160 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	76,864	27,645	37,862	-	-	-
Market Cap Growth	189.01%	-26.98%	-	-	-	-
Enterprise Value	73,468	17,671	33,014	-	-	-
Last Close Price	9520.00	3150.00	4090.00	-	-	-
PE Ratio	13.72	6.31	-	-	-	-
PS Ratio	2.04	0.97	1.39	-	-	-
PB Ratio	1.64	0.60	0.85	-	-	-
P/TBV Ratio	1.70	0.62	0.88	-	-	-
P/FCF Ratio	-	3.82	33.46	-	-	-
P/OCF Ratio	52.17	2.98	21.52	-	-	-
EV/Sales Ratio	1.95	0.62	1.21	-	-	-
EV/EBITDA Ratio	8.02	2.97	6.67	-	-	-
EV/EBIT Ratio	10.55	4.38	10.48	-	-	-
EV/FCF Ratio	-26.37	2.44	29.18	-	-	-
Debt / Equity Ratio	0.08	0.09	0.13	0.14	0.38	0.02
Debt / EBITDA Ratio	0.42	0.68	1.20	0.97	2.05	0.11
Debt / FCF Ratio	-	0.56	5.24	67.51	3.77	-
Asset Turnover	0.71	0.54	0.55	0.53	0.66	0.59
Inventory Turnover	4.06	3.02	2.25	2.59	4.69	5.25
Quick Ratio	2.41	2.92	2.08	1.29	2.61	5.74
Current Ratio	3.57	3.82	3.15	2.57	3.34	7.35
Return on Equity (ROE)	12.98%	9.63%	-4.49%	7.52%	7.51%	9.19%
Return on Assets (ROA)	8.16%	4.76%	3.97%	4.25%	6.62%	6.77%
Return on Capital (ROIC)	8.61%	5.00%	4.20%	4.57%	7.13%	7.12%
Return on Capital Employed (ROCE)	14.80%	8.70%	7.10%	9.20%	11.60%	11.80%
Earnings Yield	7.69%	15.84%	-4.91%	-	-	-
FCF Yield	-3.62%	26.21%	2.99%	-	-	-
Buyback Yield / Dilution	1.84%	-5.59%	-20.68%	11.32%	1.95%	1.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.